We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Pharma company still ‘eager’ to collaborate with Beijing, despite collapse of initial talks
Coffey dismisses guidance over additional vaccines owing to value-for-money concerns
Coroner ruling that online posts had ‘normalised’ British teenager’s condition puts pressure on tech companies
Pharma groups seek US regulatory approval as clinical trial shows monoclonal antibody treatment slowed disease
Thérèse Coffey’s lengthy wait to see a doctor highlights the imperative of tackling staff shortages
Experts are concerned that the US isn’t doing enough to support the development of the next wave of vaccines and treatments that the world needs to fight the Covid-19 pandemic
Public urged to have flu and Covid jabs as coronavirus case numbers creep up in some regions
Come for the beautiful glass bottles. Stay for the robot dispensing prescriptions
We asked our readers to share their experiences and tips on coping with anxiety and stress in young people
Help us find Britain’s healthiest workplace
The virus has not gone away — but clean air and smart policies can keep it at bay
Court ruling likely to boost spirits and ultimately transactions in the sector
Research shows taller people are more successful but leg-lengthening surgery is still a step too far
Honey & Co’s delicious three-course meal is designed to delight all your guests, whatever their dietary directives
Meta executive says policies have changed since British teen Molly Russell took her own life after viewing ‘graphic’ posts
Study of Eisai treatment will be one of last chances to prove amyloid hypothesis, say experts
You’re dealing with for-profit companies — and that means clinical compromises
Coffey aims to stem exodus of senior doctors with pension change as she tries to tackle patient backlog
‘Ambition’ for patients to expect a maximum 2-week wait as new government sets out changes to funding rules
Tofersen targets a defective gene that causes about 2% of cases of MND, also known as amyotrophic lateral sclerosis
City leaders stoke speculation on full reopening as financial hub struggles to recapture allure
Top jab makers lose combined $10bn of market value amid fears over growing public apathy
Longstanding problems with obesity and opioids left portion of population vulnerable to coronavirus
Chief US medical adviser says anti-vax attitudes could spill over and cause disease outbreaks
More than 200 years old, Cleveland Pools suffered years of neglect — and was once used as a trout farm — but has been restored to its former glory
International Edition
